Unknown

Dataset Information

0

GBP5 Serves as a Potential Marker to Predict a Favorable Response in Triple-Negative Breast Cancer Patients Receiving a Taxane-Based Chemotherapy.


ABSTRACT: Pre-operative (neoadjuvant) or post-operative (adjuvant) taxane-based chemotherapy is still commonly used to treat patients with triple-negative breast cancer (TNBC). However, there are still no effective biomarkers used to predict the responsiveness and efficacy of taxane-based chemotherapy in TNBC patients. Here we find that guanylate-binding protein 5 (GBP5), compared to other GBPs, exhibits the strongest prognostic significance in predicting TNBC recurrence and progression. Whereas GBP5 upregulation showed no prognostic significance in non-TNBC patients, a higher GBP5 level predicted a favorable recurrence and progression-free condition in the TNBC cohort. Moreover, we found that GBP5 expression negatively correlated with the 50% inhibitory concentration (IC50) of paclitaxel in a panel of TNBC cell lines. The gene knockdown of GBP5 increased the IC50 of paclitaxel in the tested TNBC cells. In TNBC patients receiving neoadjuvant or adjuvant chemotherapy, a higher GBP5 level strongly predicted a good responsiveness. Computational simulation by the Gene Set Enrichment Analysis program and cell-based assays demonstrated that GBP5 probably enhances the cytotoxic effectiveness of paclitaxel via activating the Akt/mTOR signaling axis and suppressing autophagy formation in TNBC cells. These findings suggest that GBP5 could be a good biomarker to predict a favorable outcome in TNBC patients who decide to receive a taxane-based neoadjuvant or adjuvant therapy.

SUBMITTER: Cheng SW 

PROVIDER: S-EPMC8001168 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5791378 | biostudies-literature
| S-EPMC7192942 | biostudies-literature
| S-EPMC8763743 | biostudies-literature
| S-EPMC6930158 | biostudies-literature
| S-EPMC7583464 | biostudies-literature
| S-EPMC8685522 | biostudies-literature
| S-EPMC8066311 | biostudies-literature
| S-EPMC5732731 | biostudies-literature
| S-EPMC5356512 | biostudies-literature
2024-01-05 | GSE252315 | GEO